Association between the 21-gene recurrence score assay (RS) and risk of locoregional failure in node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

被引：0
|
作者：
Mamounas, E
Tang, G
Bryant, J
Paik, S
Shak, S
Costantino, J
Watson, D
Wickerham, DL
Wolmark, N
机构：
[1] NSABP, Pittsburgh, PA USA
[2] Aultman Hlth Fdn, Canton, OH USA
[3] Genom Hlth Inc, Redwood City, CA USA
[4] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [1] Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
    Mamounas, Eleftherios P.
    Tang, Gong
    Fisher, Bernard
    Paik, Soonmyung
    Shak, Steven
    Costantino, Joseph P.
    Watson, Drew
    Geyer, Charles E., Jr.
    Wickerham, D. Lawrence
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (10) : 1677 - 1683
  • [2] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Tang, Gong
    Shak, Steven
    Paik, Soonmyung
    Anderson, Stewart J.
    Costantino, Joseph P.
    Geyer, Charles E., Jr.
    Mamounas, Eleftherios P.
    Wickerham, D. Lawrence
    Wolmark, Norman
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (01) : 133 - 142
  • [3] Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
    Gong Tang
    Steven Shak
    Soonmyung Paik
    Stewart J. Anderson
    Joseph P. Costantino
    Charles E. Geyer
    Eleftherios P. Mamounas
    D. Lawrence Wickerham
    Norman Wolmark
    Breast Cancer Research and Treatment, 2011, 127 : 133 - 142
  • [4] Association between the 21-gene recurrence score (RS) and benefit from adjuvant paclitaxel (Pac) in node-positive (N plus ), ER-positive breast cancer patients (pts): Results from NSABP B-28
    Mamounas, E. P.
    Tang, G.
    Paik, S.
    Baehner, F. L.
    Liu, Q.
    Jeong, J-H
    Kim, S-R
    Butler, S. M.
    Jamshidian, F.
    Cherbavaz, D. B.
    Sing, A. P.
    Shak, S.
    Julian, T. B.
    Lembersky, B. C.
    Wickerham, D. L.
    Costantino, J. P.
    Wolmark, N.
    CANCER RESEARCH, 2012, 72
  • [5] Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer.
    Paik, S
    Shak, S
    Tang, G
    Kim, C
    Baker, J
    Cronin, M
    Watson, D
    Bryant, J
    Costantino, J
    Wolmark, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 6S - 6S
  • [6] Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20
    Paik, S
    Shak, S
    Tang, G
    Kim, C
    Joo, H
    Baker, J
    Cronin, M
    Watson, D
    Braynt, J
    Costantino, J
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S15 - S15
  • [7] Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients - NSABP studies B-20 and B-14
    Paik, S
    Shak, S
    Tang, G
    Kim, C
    Baker, J
    Cronin, M
    Baehner, R
    Walker, M
    Watson, D
    Park, T
    Bryant, J
    Wolmark, N
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S10 - S11
  • [8] Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28.
    Mamounas, Eleftherios P.
    Tang, Gong
    Paik, Soonmyung
    Baehner, Frederick L.
    Liu, Qing
    Jeong, Jong-Hyeon
    Kim, Seong-Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [9] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Gulisa Turashvili
    Joanne F. Chou
    Edi Brogi
    Monica Morrow
    Maura Dickler
    Larry Norton
    Clifford Hudis
    Hannah Y. Wen
    Breast Cancer Research and Treatment, 2017, 166 : 69 - 76
  • [10] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Turashvili, Gulisa
    Chou, Joanne F.
    Brogi, Edi
    Morrow, Monica
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 69 - 76
12345